Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
11,637,870
-
Shares change
-
+379,497
-
Total reported value, excl. options
-
$1,381,764,563
-
Value change
-
+$46,463,709
-
Put/Call ratio
-
64%
-
Number of buys
-
51
-
Number of sells
-
-56
-
Price
-
$118.73
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q3 2020
152 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q3 2020.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,637,870 shares
of 23,267,064 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1,885,327 shares), BAKER BROS. ADVISORS LP (1,499,213 shares), HealthCor Management, L.P. (1,129,948 shares), Avoro Capital Advisors LLC (890,000 shares), WELLINGTON MANAGEMENT GROUP LLP (789,903 shares), VANGUARD GROUP INC (766,504 shares), BlackRock Inc. (657,694 shares), ALLIANCEBERNSTEIN L.P. (563,962 shares), STATE STREET CORP (431,244 shares), and ARMISTICE CAPITAL, LLC (278,000 shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.